Artificial intelligence-based analysis and diagnosis of intradural extramedullary spinal tumors by stimulated Raman histology
Neuro-Oncology Advances · 06.01.2025 · 7 (1)
DOI: 10.1093/noajnl/vdaf211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 08.10.2025. Verfasst von Pierre Scheffler und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
AbstractAbstract Background Intraoperative Stimulated Raman Histology (SRH) has been reported to be fast and accurate in the assessment of neuro-oncological lesions. However, its application to spinal tumors, especially intradural extramedullary tumors (IDEM), remains underexplored. IDEM primarily include meningiomas and schwannomas, as well as less common entities such as metastases or ependymomas. Given that surgical resection is the primary treatment modality, rapid, artificial intelligence (AI)-driven intraoperative tumor classification based on SRH could enhance surgical decision-making and subsequent management.
Methods
We acquired 232 SRH images from patients with IDEM using the NIO Laser Imaging System (Invenio Imaging Inc.). We categorized images into three diagnostic classes: “Meningioma,” “Schwannoma,” and “Other.” Images were divided into 224 × 224 pixel patches and used to train and test AI-based image classifiers employing CTransPath, ResNet, and Vision Transformer architectures.
Results
Our best-performing model, utilizing the CTransPath architecture, achieved a classification accuracy of 94.3% on the test dataset. Vision Transformer-based models also performed well, exceeding 90% accuracy, while ResNet models attained slightly lower accuracies (79.6%-88.8%). Qualitative analysis indicates that the top-performing model primarily relies on cellular morphology for classification.
Conclusions
Our findings confirm the feasibility and effectiveness of AI-assisted SRH analysis for distinguishing IDEM tumor types. This approach may complement conventional intraoperative neuropathology by providing rapid, reliable, and clinically actionable diagnostic information.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Medical Center, University of Freiburg, Freiburg, Germany.
- Center for Advanced Surgical Tissue analysis (CAST), University of Freiburg, Freiburg, Germany.
- German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
- Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Department of Neurosurgery, University Hospital Erlangen, Erlangen, Germany.
- Microenvironment and Immunology Research Laboratory, Friedrich-Alexander University of Nürnberg-Erlangen, Erlangen, Germany.
ORCID-Profile: Pierre Scheffler, Marco Prinz, Amir El Rahal
Zitieren
APA
Scheffler, P., Neidert, N., Straehle, J., Erny, D., Prinz, M., Hubbe, U., Rölz, R., Heiland, D. H., Beck, J., & El Rahal, A. (2025). Artificial intelligence-based analysis and diagnosis of intradural extramedullary spinal tumors by stimulated Raman histology. Neuro-Oncology Advances, 7(1). https://doi.org/10.1093/noajnl/vdaf211
Vancouver
Scheffler P, Neidert N, Straehle J, Erny D, Prinz M, Hubbe U, et al. Artificial intelligence-based analysis and diagnosis of intradural extramedullary spinal tumors by stimulated Raman histology. Neuro-Oncology Advances. 2025;7(1). doi:10.1093/noajnl/vdaf211
BibTeX
@article{Scheffler2025,
author = {Scheffler, Pierre and Neidert, Nicolas and Straehle, Jakob and Erny, Daniel and Prinz, Marco and Hubbe, Ulrich and Rölz, Roland and Heiland, Dieter Henrik and Beck, Jürgen and El Rahal, Amir},
title = {Artificial intelligence-based analysis and diagnosis of intradural extramedullary spinal tumors by stimulated Raman histology},
journal = {Neuro-Oncology Advances},
year = {2025},
volume = {7},
number = {1},
doi = {10.1093/noajnl/vdaf211}
}
EUVIMED